Clinical Trial Update: Clinical Study to Evaluate the Efficacy and Safety of DA-2803 in Chronic Hepatitis B Patients [Phase 4]

View source ↗

Summary

The clinical trial update states that the Phase 4 study of DA-2803 in chronic hepatitis B has completed. No efficacy or safety results are disclosed in the snip…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• DA-2803

Snippet

Sponsor: Dong-A ST Co., Ltd. | Conditions: Hepatitis B | Phase 4 | Status: COMPLETED